Semaphorin Signaling in Cardiovascular Development
Jonathan A. Epstein(California Institute for Regenerative Medicine), Manvendra K. Singh(National Heart Centre Singapore), Haig Aghajanian(Therapeutics Clinical Research)
Cited by 118
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|792
Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force
|Genetics in Medicine|2002|398
Plasticity of Hopx+ type I alveolar cells to regenerate type II cells in the lung
|Nature Communications|2015|309
Immune Cells and Immunotherapy for Cardiac Injury and Repair
|Circulation Research|2021|267